On January 26, 2016, a motion for authority to pay claims of vendors was filed in the bankruptcy case of Nuo Therapeutics, Inc. (f/k/a Cytomedix, Inc.) and its affiliates.
The filing was assigned docket number 16 and is described on the court’s official docket as follows:
Motion to Pay Critical Trade Vendor Claims // Debtor’s Motion for an Order Pursuant to Sections 105(a), 363(b), 1107, and 1108 of the Bankruptcy Code Authorizing, but not Requiring, Payment of Prepetition Claims of Certain Vendors Filed By Nuo Therapeutics, Inc. (Skomorucha Owens, Karen) (Entered: 01/26/2016)
Nuo Therapeutics, Inc. (f/k/a Cytomedix, Inc.) filed for bankruptcy protection, or had an involuntary bankruptcy petition filed against it, on January 26, 2016. The bankruptcy case is pending before the United States Bankruptcy Court for the District of Delaware. The case number for the lead bankruptcy case is 16-10192. The bankruptcy case is currently assigned to United States Bankruptcy Judge Mary Walrath. The law firm of Dentons US LLP is acting as lead bankruptcy counsel to Nuo Therapeutics, Inc. (f/k/a Cytomedix, Inc.) in the bankruptcy case.